Inside the Health Data Industry's Opaque Diagnosis: A Q&A With Author of 'Our Bodies, Our Data'
Posted in: Uncategorized
As the Reuters bureau chief for the Balkans living in Serbia from 2008-2011, Adam Tanner grew accustomed to maneuvering in the shadows in places with authoritarian tendencies in the hopes of illuminating what was really happening in government and society. Turns out his experiences attempting to uncover practices of the data industry aren’t much different in that way.
“Having also worked for five years in Russia in the 1990s, I would say the similarities are that there are many opaque corners of these societies that authorities would rather not shed light on,” said Mr. Tanner, author of “Our Bodies, Our Data,” his second book on the topic of the data industry. “Similarly, many in the big health data bazaar would prefer to continue their lucrative trade without much public attention.”
The fact that the health, pharma and medical data sector, not unlike the data industry as a whole, is less-than-transparent is no secret. In fact, the subject has been covered here in Ad Age (which, coincidentally, has its roots in the medical industry through Crain’s very first publication in 1916, Hospital Management).
Post a Comment